Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system

被引:9
作者
Katoh, Norio [1 ,2 ]
Soda, Itaru [3 ]
Tamamura, Hiroyasu [4 ]
Takahashi, Shotaro [5 ]
Uchinami, Yusuke [6 ]
Ishiyama, Hiromichi [3 ]
Ota, Kiyotaka [4 ]
Inoue, Tetsuya [1 ]
Onimaru, Rikiya [6 ]
Shibuya, Keiko [5 ]
Hayakawa, Kazushige [3 ]
Shirato, Hiroki [2 ,6 ]
机构
[1] Hokkaido Univ Hosp, Dept Radiat Oncol, Kita Ku, North 14 West 5, Sapporo, Hokkaido, Japan
[2] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Quantum Med Sci & Engn, Sapporo, Hokkaido, Japan
[3] Kitasato Univ, Dept Radiol & Radiat Oncol, Sch Med, Sagamihara, Kanagawa, Japan
[4] Fukui Prefectural Hosp, Dept Nucl Med, Fukui, Japan
[5] Yamaguchi Univ, Dept Therapeut Radiol, Grad Sch Med, Ube, Yamaguchi, Japan
[6] Hokkaido Univ, Dept Radiat Med, Grad Sch Med, Sapporo, Hokkaido, Japan
来源
RADIATION ONCOLOGY | 2017年 / 12卷
关键词
Stereotactic body radiotherapy; Non-small cell lung cancer; Real-time tumor-tracking radiotherapy; Gated radiotherapy; Image-guided radiotherapy; DOSE-RESPONSE RELATIONSHIP; RADIATION-THERAPY; ABLATIVE RADIOTHERAPY; GATED RADIOTHERAPY; RESPIRATORY MOTION; FIDUCIAL MARKERS; PNEUMONITIS; LOBECTOMY; SETUP; IRRADIATION;
D O I
10.1186/s13014-016-0742-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the clinical outcomes of stage I and IIA non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT) using a real-time tumor-tracking radiotherapy (RTRT) system. Materials and methods: Patterns-of-care in SBRT using RTRT for histologically proven, peripherally located, stage I and IIA NSCLC was retrospectively investigated in four institutions by an identical clinical report format. Patterns-of-outcomes was also investigated in the same manner. Results: From September 2000 to April 2012, 283 patients with 286 tumors were identified. The median age was 78 years (52-90) and the maximum tumor diameters were 9 to 65 mm with a median of 24 mm. The calculated biologically effective dose (10) at the isocenter using the linear-quadratic model was from 66 Gy to 126 Gy with a median of 106 Gy. With a median follow-up period of 28 months (range 0-127), the overall survival rate for the entire group, for stage IA, and for stage IB + IIA was 75%, 79%, and 65% at 2 years, and 64%, 70%, and 50% at 3 years, respectively. In the multivariate analysis, the favorable predictive factor was female for overall survival. There were no differences between the clinical outcomes at the four institutions. Grade 2, 3, 4, and 5 radiation pneumonitis was experienced by 29 (10.2%), 9 (3.2%), 0, and 0 patients. The subgroup analyses revealed that compared to margins from gross tumor volume (GTV) to planning target volume (PTV) >= 10 mm, margins < 10 mm did not worsen the overall survival and local control rates, while reducing the risk of radiation pneumonitis. Conclusions: This multi-institutional retrospective study showed that the results were consistent with the recent patterns-of-care and patterns-of-outcome analysis of SBRT. A prospective study will be required to evaluate SBRT using a RTRT system with margins from GTV to PTV < 10mm.
引用
收藏
页数:10
相关论文
共 44 条
  • [1] A DOSE-VOLUME ANALYSIS OF RADIATION PNEUMONITIS IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH STEREOTACTIC BODY RADIATION THERAPY
    Barriger, R. Bryan
    Forquer, Jeffrey A.
    Brabham, Jeffrey G.
    Andolino, David L.
    Shapiro, Ronald H.
    Henderson, Mark A.
    Johnstone, Peter A. S.
    Fakiris, Achilles J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 457 - 462
  • [2] Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs
    Bongers, Eva M.
    Botticella, Angela
    Palma, David A.
    Haasbeek, Cornelis J. A.
    Warner, Andrew
    Verbakel, Wilko F. A. R.
    Slotman, Ben
    Ricardi, Umberto
    Senan, Suresh
    [J]. RADIOTHERAPY AND ONCOLOGY, 2013, 109 (01) : 95 - 99
  • [3] Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy
    Borst, Gerben R.
    Ishikawa, Masayori
    Nijkamp, Jasper
    Hauptmann, Michael
    Shirato, Hiroki
    Onimaru, Rikiya
    van den Heuvel, Michel M.
    Belderbos, Jose
    Lebesque, Joos V.
    Sonke, Jan-Jakob
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 91 (03) : 307 - 313
  • [4] Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
    Chang, Joe Y.
    Senan, Suresh
    Paul, Marinus A.
    Mehran, Reza J.
    Louie, Alexander V.
    Balter, Peter
    Groen, Harry J. M.
    McRae, Stephen E.
    Widder, Joachim
    Feng, Lei
    van den Borne, Ben E. E. M.
    Munsell, Mark F.
    Hurkmans, Coen
    Berry, Donald A.
    van Werkhoven, Erik
    Kresl, John J.
    Dingemans, Anne-Marie
    Dawood, Omar
    Haasbeek, Cornelis J. A.
    Carpenter, Larry S.
    De Jaeger, Katrien
    Komaki, Ritsuko
    Slotman, Ben J.
    Smit, Egbert F.
    Roth, Jack A.
    [J]. LANCET ONCOLOGY, 2015, 16 (06) : 630 - 637
  • [5] Image-guided radiotherapy: rationale, benefits, and limitations
    Dawson, Laura A.
    Sharpe, Michael B.
    [J]. LANCET ONCOLOGY, 2006, 7 (10) : 848 - 858
  • [6] Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A)
    Eba, Junko
    Nakamura, Kenichi
    Mizusawa, Junki
    Suzuki, Kenji
    Nagata, Yasushi
    Koike, Teruaki
    Hiraoka, Masahiro
    Watanabe, Shun-ichi
    Ishikura, Satoshi
    Asamura, Hisao
    Fukuda, Haruhiko
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (08) : 748 - 753
  • [7] Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning
    Giraud, P
    Antoine, M
    Larrouy, A
    Milleron, B
    Callard, P
    De Rycke, Y
    Carette, MF
    Rosenwald, JC
    Cosset, JM
    Housset, M
    Touboul, E
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (04): : 1015 - 1024
  • [8] Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy
    Guckenberger, Matthias
    Klement, Rainer J.
    Allgaeuer, Michael
    Andratschke, Nicolaus
    Blanck, Oliver
    Boda-Heggemann, Judit
    Dieckmann, Karin
    Duma, Marciana
    Ernst, Iris
    Ganswindt, Ute
    Hass, Peter
    Henkenberens, Christoph
    Holy, Richard
    Imhoff, Detlef
    Kahl, Henning K.
    Krempien, Robert
    Lohaus, Fabian
    Nestle, Ursula
    Nevinny-Stickel, Meinhard
    Petersen, Cordula
    Semrau, Sabine
    Streblow, Jan
    Wendt, Thomas G.
    Wittig, Andrea
    Flentje, Michael
    Sterzing, Florian
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 118 (03) : 485 - 491
  • [9] Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non-Small-Cell Lung Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis
    Guckenberger, Matthias
    Allgaeuer, Michael
    Appold, Steffen
    Dieckmann, Karin
    Ernst, Iris
    Ganswindt, Ute
    Holy, Richard
    Nestle, Ursula
    Nevinny-Stickel, Meinhard
    Semrau, Sabine
    Sterzing, Florian
    Wittig, Andrea
    Andratschke, Nicolaus
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (08) : 1050 - 1058
  • [10] Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy
    Guckenberger, Matthias
    Baier, Kurt
    Polat, Buelent
    Richter, Anne
    Krieger, Thomas
    Wilbert, Juergen
    Mueller, Gerd
    Flentje, Michael
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 97 (01) : 65 - 70